Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05557864 · ClinicalTrials.gov registry record · NA

Effects of Pallidal Deep Brain Stimulation Location on Motor Impairment in Parkinson's Disease

A NA study of Parkinson's Disease, sponsored by University of Minnesota.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT05557864 is a NA study of Parkinson's Disease that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 24 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05557864, a NA study of Parkinson's Disease, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This protocol will characterize the effects of deep brain stimulation (DBS) location (both adverse and beneficial) on motor signs in people with Parkinson's disease (PD). This information can be used to inform future DBS protocols to tailor stimulation to the specific needs of a patient. If targeted dorsal GP stimulation is shown to significantly improve motor features that are typically resistant to dopamine replacement therapy, these experiments will likely have major impact on clinical practice by providing a potential strategy to these medically intractable symptoms.

Conditions Studied

Interventions

  • DEVICE Deep Brain Stimulation

Study Locations (1)

Minnesota

  • University Of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2016-08-25
Est. Completion 2026-12-31
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT05557864

The ClinicalTrials.gov registry entry for NCT05557864 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (96% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which Deep Brain Stimulation is the first listed.

NCT05557864 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05557864 about?

NCT05557864 is a clinical study titled "Effects of Pallidal Deep Brain Stimulation Location on Motor Impairment in Parkinson's Disease". This protocol will characterize the effects of deep brain stimulation (DBS) location (both adverse and beneficial) on motor signs in people with Parkinson's disease (PD). This information can be used to inform future DBS protocols to tailor stimulation to the specific needs of a patient. If targeted...

What is the current status of trial NCT05557864?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2016-08-25. Estimated completion is 2026-12-31.

What conditions does trial NCT05557864 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT05557864?

The interventions under investigation include: Deep Brain Stimulation (DEVICE).

Who is sponsoring clinical trial NCT05557864?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05557864 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.